Recombinant Human Interferon α2a (Wuhan Wei'Ao)

重组人干扰素α2a栓 (武汉维奥)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant Human Interferon α2a (Wuhan Wei'Ao)
Drug Alias Name奥平
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsVirus Diseases
Approved Indications in ChinaVirus Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWuhan Wei'Ao Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Wei'Ao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeL03AB04
Related LinksN/A